Viewing Study NCT06145633


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-06-23 @ 10:19 PM
Study NCT ID: NCT06145633
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2023-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration-Resistant Prostate Carcinoma View
None Metastatic Prostate Adenocarcinoma View
None Stage IVB Prostate Cancer AJCC v8 View
Keywords: